186 related articles for article (PubMed ID: 15616035)
1. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy.
Wang JJ; Zhang SX; Lu K; Chen Y; Mott R; Sato S; Ma JX
Diabetes; 2005 Jan; 54(1):243-50. PubMed ID: 15616035
[TBL] [Abstract][Full Text] [Related]
2. Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities.
Wang JJ; Zhang SX; Mott R; Knapp RR; Cao W; Lau K; Ma JX
Diabetes; 2006 Jun; 55(6):1678-85. PubMed ID: 16731830
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
Wang JJ; Zhang SX; Mott R; Chen Y; Knapp RR; Cao W; Ma JX
Am J Physiol Renal Physiol; 2008 May; 294(5):F1166-73. PubMed ID: 18322021
[TBL] [Abstract][Full Text] [Related]
4. Pigment epithelium-derived factor inhibits high glucose induced oxidative stress and fibrosis of cultured human glomerular mesangial cells.
Mao T; Gao L; Li H; Li J
Saudi Med J; 2011 Aug; 32(8):769-77. PubMed ID: 21858384
[TBL] [Abstract][Full Text] [Related]
5. Pigment epithelium-derived factor inhibits high glucose-induced JAK/STAT signalling pathway activation in human glomerular mesangial cells.
Mao T; Chen H; Hong L; Li J
Saudi Med J; 2013 Aug; 34(8):793-800. PubMed ID: 23974449
[TBL] [Abstract][Full Text] [Related]
6. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
Yoshida Y; Yamagishi S; Matsui T; Jinnouchi Y; Fukami K; Imaizumi T; Yamakawa R
Diabetes Metab Res Rev; 2009 Oct; 25(7):678-86. PubMed ID: 19685553
[TBL] [Abstract][Full Text] [Related]
7. Pigment epithelium‑derived factor protects human glomerular mesangial cells from diabetes via NOXO1‑iNOS suppression.
Gao L; Hu Y; Li J
Mol Med Rep; 2017 Nov; 16(5):7855-7863. PubMed ID: 28944893
[TBL] [Abstract][Full Text] [Related]
8. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
Ide Y; Matsui T; Ishibashi Y; Takeuchi M; Yamagishi S
Microvasc Res; 2010 Sep; 80(2):227-32. PubMed ID: 20381502
[TBL] [Abstract][Full Text] [Related]
9. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes.
Amano S; Yamagishi S; Inagaki Y; Nakamura K; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2005 Jan; 69(1-2):45-55. PubMed ID: 15797260
[TBL] [Abstract][Full Text] [Related]
10. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.
Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX
FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716
[TBL] [Abstract][Full Text] [Related]
11. Protective Role of PEDF-Derived Synthetic Peptide Against Experimental Diabetic Nephropathy.
Ishibashi Y; Matsui T; Taira J; Higashimoto Y; Yamagishi S
Horm Metab Res; 2016 Sep; 48(9):613-9. PubMed ID: 27214310
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of pigment epithelium-derived factor within the penile tissues contributes to erectile dysfunction in diabetic rats.
Qiao H; Zhang Y; Lin W; Wang YF; Furdui CM; Jiang Q; Li X; Long T; Wang Y; Qin DN
Clin Sci (Lond); 2018 Oct; 132(20):2175-2188. PubMed ID: 30232174
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor regulation of pigment epithelial-derived factor expression in rat retina.
Lashbrook BL; Steinle JJ
Auton Neurosci; 2005 Aug; 121(1-2):33-9. PubMed ID: 15961351
[TBL] [Abstract][Full Text] [Related]
14. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
[TBL] [Abstract][Full Text] [Related]
15. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
Fujimura T; Yamagishi S; Ueda S; Fukami K; Shibata R; Matsumoto Y; Kaida Y; Hayashida A; Koike K; Matsui T; Nakamura K; Okuda S
Nephrol Dial Transplant; 2009 May; 24(5):1397-406. PubMed ID: 19042927
[TBL] [Abstract][Full Text] [Related]
16. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex.
Che D; Fang Z; Yan L; Du J; Li F; Xie J; Feng J; Yin P; Qi W; Yang Z; Ma J; Yang X; Gao G; Zhou T
Diabetologia; 2020 Sep; 63(9):1857-1871. PubMed ID: 32377760
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effects and transcriptional regulation of pigment epithelium-derived factor in diabetic retinopathy.
Wang B; Atherton P; Patel R; Manning G; Donnelly R
Microvasc Res; 2010 Jul; 80(1):31-6. PubMed ID: 20219495
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelium derived factor play a positive role in bone mineralization of osteoblasts derived from diabetic patients.
Song N; Zhong J; Zhang J; Yu J; Li J; Qi J; Yang J; Qiu Y; Su W; Feng Z; Wang H
Gene; 2017 Sep; 627():563-568. PubMed ID: 28698158
[TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) inhibits proximal tubular cell injury in early diabetic nephropathy by suppressing advanced glycation end products (AGEs)-receptor (RAGE) axis.
Maeda S; Matsui T; Takeuchi M; Yoshida Y; Yamakawa R; Fukami K; Yamagishi S
Pharmacol Res; 2011 Mar; 63(3):241-8. PubMed ID: 21115116
[TBL] [Abstract][Full Text] [Related]
20. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
